Feed Preview
Influential
HIV: Cell & Gene Therapy
This feed focuses on emerging cell and gene therapies, such as HIV vaccines, for treating patients living with HIV/AIDS. Discover the latest research here.
Top 20 most recent papers
HCV or HBV coinfection and lymphoma risk in people living with HIV
AIDSDecember 14, 2019
Caroline BessonLymphovir and FHDH study groups
4
1
The Estimation and Projection Package Age-Sex Model and the r-hybrid model: new tools for estimating HIV incidence trends in sub-Saharan Africa
AIDSDecember 5, 2019
Jeffrey W EatonTimothy B Hallett
Science communication in online media: influence of press releases on coverage of genetics and CRISPR
bioRxivDecember 16, 2019
Rafał Grochala
8
Machine learning classification of neurocognitive performance in children with perinatal HIV initiating de novo antiretroviral therapy
AIDSJanuary 3, 2020
Robert H PaulPREDICT Study Group
4
Parameter estimates for trends and patterns of excess mortality among persons on antiretroviral therapy in high-income European settings
AIDSDecember 5, 2019
Adam TrickeyMargaret T May
1
Inhibition of Vif-mediated degradation of APOBEC3G through competitive binding of Core-binding factor beta (CBFβ)
Journal of VirologyJanuary 17, 2020
Eri MiyagiKlaus Strebel
Week 96 results of a phase 3 trial of darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-naïve HIV-1 patients
AIDSDecember 14, 2019
Chloe OrkinAMBER study group
1
1
High levels of genetically-intact HIV in HLA-DR+ memory T-cells indicates their value for reservoir studies
AIDSJanuary 9, 2020
Bethany A HorsburghSarah Palmer
5
Monocytes from men living with HIV exhibit heightened atherogenic potential despite long term viral suppression with ART
AIDSDecember 10, 2019
Thomas A AngelovichAnthony Jaworowski
7
1
Presence of Tat and transactivation response element in spinal fluid despite antiretroviral therapy
AIDSDecember 4, 2019
Lisa J HendersonAvindra Nath
Viral suppression and factors associated with failure to achieve viral suppression among pregnant women in South Africa: a national cross-sectional survey
AIDSDecember 11, 2019
Selamawit A WoldesenbetAdrian J Puren
4
HIV surveillance based on routine testing data from antenatal clinics in Malawi (2011-2018): measuring and adjusting for bias from imperfect testing coverage
AIDSDecember 6, 2019
Mathieu Maheu-GirouxJeffrey W Eaton
9
1
Structural Fluidity of the Human Immunodeficiency Virus Rev Response Element
VirusesJanuary 17, 2020
Chringma Sherpa, Stuart F J Le Grice
Potential for early antiretroviral therapy to reduce central nervous system HIV-1 persistence
AIDSDecember 4, 2019
Serena SpudichMagnus Gisslen
Pre-exposure prophylaxis for msm in the netherlands: impact on hiv and n.gonorrhoeae transmission and cost-effectiveness
AIDSJanuary 3, 2020
Maarten ReitsemaMaria Xiridou
Updates to the Spectrum/AIM model for estimating key HIV indicators at national and subnational levels
AIDSDecember 6, 2019
John StoverConstantin Yiannoutsos
3
3
Symptomatic cerebrospinal fluid escape
AIDSDecember 4, 2019
Andrea MastrangeloPaola Cinque
Rilpivirine-associated aggregation-induced emission enables cell-based nanoparticle tracking
BiomaterialsDecember 23, 2019
Insiya Z MukadamBhavesh D Kevadiya
1
Challenges of scale-up to Dolutegravir based regimens in sub-Saharan Africa: a case study in Togo
AIDSJanuary 3, 2020
Mounerou SalouMartine Peeters
3
The Safety and Immunogenicity of GTU® MultiHIV DNA Vaccine Delivered by Transcutaneous and Intramuscular Injection With or Without Electroporation in HIV-1 Positive Subjects on Suppressive ART
Frontiers in ImmunologyJanuary 11, 2020
G HaidariRobin J Shattock